Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
2201
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $679K | ﹤0.01% |
30,546
+2,746
| +10% | +$55.5K |
|
2202
Fabrinet
FN
$20.3B
| $678K | ﹤0.01% |
32,892
+8,392
| +34% | +$170K |
|
|
DX
2203
Dynex Capital
DX
$3.23B
| $672K | ﹤0.01% |
25,302
-26,849
| -51% | -$691K |
|
|
TEU
2204
DELISTED
BOX SHIPS INCORPORATED SHS (MARSHALL ISLANDS)
TEU
| $672K | ﹤0.01% |
444,784
+210,608
| +90% | +$352K |
|
2205
Capital City Bank Group
CCBG
$896M
| $669K | ﹤0.01% |
46,073
+466
| +1% | +$6.33K |
|
2206
Horizon Bancorp
HBNC
$1.05B
| $669K | ﹤0.01% |
68,963
-24,153
| -26% | -$227K |
|
|
AIRM
2207
DELISTED
Air Methods Corp
AIRM
| $666K | ﹤0.01% |
12,900
-493,854
| -97% | -$25.1M |
|
2208
AMCON Distributing
DIT
$66.4M
| $662K | ﹤0.01% |
12,150
+2,400
| +25% | +$131K |
|
2209
Martin Marietta Materials
MLM
$32.7B
| $660K | ﹤0.01% |
5,000
| – | – |
|
2210
H.B. Fuller
FUL
$3.24B
| $659K | ﹤0.01% |
13,700
-250,173
| -95% | -$12M |
|
|
ESCR
2211
DELISTED
ESCALERA RESOURCES CO
ESCR
| $656K | ﹤0.01% |
+249,100
| New | +$688K |
|
|
GBNK
2212
DELISTED
Guaranty Bancorp
GBNK
| $655K | ﹤0.01% |
47,120
+22
| +0% | +$297 |
|
|
POZN
2213
DELISTED
POZEN INC
POZN
| $652K | ﹤0.01% |
78,319
-159,799
| -67% | -$1.37M |
|
|
JNP
2214
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $649K | ﹤0.01% |
94,750
-29,300
| -24% | -$196K |
|
|
TUMI
2215
DELISTED
TUMI HLDGS INC COM
TUMI
| $646K | ﹤0.01% |
32,100
+17,985
| +127% | +$363K |
|
2216
NovaGold Resources
NG
$3.45B
| $643K | ﹤0.01% |
152,700
-668,500
| -81% | -$2.36M |
|
|
CNTF
2217
DELISTED
China TechFaith Wireless Communication Technology Ltd
CNTF
| $643K | ﹤0.01% |
99,680
-3,980
| -4% | -$31.3K |
|
2218
Vitamin Cottage Natural Grocers
NGVC
$632M
| $640K | ﹤0.01% |
+29,900
| New | +$822K |
|
|
ENFY
2219
DELISTED
Enlightify Inc
ENFY
| $640K | ﹤0.01% |
24,242
-11,032
| -31% | -$342K |
|
|
SHLM
2220
DELISTED
Schulman (A.) Inc
SHLM
| $635K | ﹤0.01% |
16,400
-51,200
| -76% | -$1.84M |
|
2221
Smith Micro Software
SMSI
$16.2M
| $632K | ﹤0.01% |
3,796
-57
| -1% | -$11.3K |
|
2222
Deswell Industries
DSWL
$50.7M
| $631K | ﹤0.01% |
306,100
-9,019
| -3% | -$18.9K |
|
|
GST
2223
DELISTED
Gastar Exploration Inc.
GST
| $630K | ﹤0.01% |
+72,280
| New | +$510K |
|
|
EXAC
2224
DELISTED
Exactech Inc
EXAC
| $630K | ﹤0.01% |
24,981
+7,181
| +40% | +$166K |
|
|
DGAS
2225
DELISTED
Delta Natural Gas Co Inc
DGAS
| $630K | ﹤0.01% |
28,700
+12,201
| +74% | +$240K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.